WebApr 12, 2024 · Zacks Rank & Stock to Consider. Curis currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the biotech sector is Voyager Therapeutics, Inc. VYGR, which has a Zacks Rank #2 (Buy) at ... WebDec 23, 2024 · Curis, Inc. (NASDAQ:CRIS) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we'd rather spend our time researching ...
Curis (CRIS) Surges: Stock Moves 5% Higher - Yahoo!
WebMay 13, 2024 · Accordingly, the stock has a Strong Buy consensus rating, backed by a $21 average price target. Investors could be pocketing gains of 54%, should the target be met over the coming months. WebNov 2, 2024 · This drug developer is expected to post quarterly loss of $0.13 per share in its upcoming report, which represents a year-over-year change of -18.2%. Revenues are expected to be $2.66 million, down... georgia bulldogs football schedule 2022 tv
Do Options Traders Know Something About Curis (CRIS) Stock We ... - Yahoo!
WebMay 13, 2024 · That was down from the year-ago quarter's $2.71 million, and missed the average analyst estimate of $2.75 million, according to data compiled by Yahoo! Finance. Image source: Getty Images. WebApr 9, 2024 · Curis (NASDAQ:CRIS) has a market capitalization of $58.94 million and generates $10.16 million in revenue each year. The biotechnology company earns $ … christianity magazine